NasdaqGM - Nasdaq Real Time Price USD

Cerus Corporation (CERS)

1.2900
-0.0700
(-5.15%)
At close: May 9 at 4:00:00 PM EDT
1.2992
+0.01
+(0.71%)
After hours: May 9 at 7:46:25 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
185,144
180,270
156,367
162,048
130,859
Cost of Revenue
81,470
80,748
69,967
74,954
63,475
Gross Profit
103,674
99,522
86,400
87,094
67,384
Operating Expense
115,773
113,747
112,725
121,175
116,320
Operating Income
-12,099
-14,225
-26,325
-34,081
-48,936
Net Non Operating Interest Income Expense
-8,753
-8,877
-8,386
-5,831
-4,923
Other Income Expense
2,068
2,346
-2,611
-2,425
-198
Pretax Income
-18,784
-20,756
-37,322
-42,337
-54,057
Tax Provision
205
205
325
488
319
Net Income Common Stockholders
-18,947
-20,918
-37,489
-42,779
-54,374
Diluted NI Available to Com Stockholders
-18,947
-20,918
-37,489
-42,779
-54,374
Basic EPS
-0.10
--
-0.21
-0.24
-0.32
Diluted EPS
-0.10
--
-0.21
-0.24
-0.32
Basic Average Shares
185,807
--
180,270
176,545
171,279
Diluted Average Shares
185,807
--
180,270
176,545
171,279
Total Operating Income as Reported
-12,099
-14,225
-30,053
-34,081
-48,936
Total Expenses
197,243
194,495
182,692
196,129
179,795
Net Income from Continuing & Discontinued Operation
-18,947
-20,918
-37,489
-42,779
-54,374
Normalized Income
-18,909.8000
-21,210.3000
-34,031.9600
-42,233.9000
-53,956.4400
Interest Expense
8,753
8,877
8,386
5,831
4,923
Net Interest Income
-8,753
-8,877
-8,386
-5,831
-4,923
EBIT
-10,031
-11,879
-28,936
-36,506
-49,134
EBITDA
-8,500
-10,024
-26,337
-33,522
-45,986
Reconciled Cost of Revenue
81,470
80,748
69,967
74,954
63,475
Reconciled Depreciation
1,531
1,855
2,599
2,984
3,148
Net Income from Continuing Operation Net Minority Interest
-18,947
-20,918
-37,489
-42,779
-54,374
Total Unusual Items Excluding Goodwill
-62
370
-4,376
-690
-572
Total Unusual Items
-62
370
-4,376
-690
-572
Normalized EBITDA
-8,438
-10,394
-21,961
-32,832
-45,414
Tax Rate for Calcs
0.0004
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-24.8000
77.7000
-918.9600
-144.9000
-154.4400
12/31/2021 - 1/31/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PACB Pacific Biosciences of California, Inc.
1.1200
-6.67%
 
RCEL AVITA Medical, Inc.
6.97
-25.29%
 
CTSO Cytosorbents Corporation
0.8710
+0.11%
 
LAB Standard BioTools Inc.
1.0700
-4.04%
 
SSKN STRATA Skin Sciences, Inc.
2.4600
-4.65%
 
ATEC Alphatec Holdings, Inc.
12.21
-4.16%
 
INGN Inogen, Inc.
6.24
-1.73%
 
OFIX Orthofix Medical Inc.
12.11
-1.62%
 
RPID Rapid Micro Biosystems, Inc.
3.0800
+25.71%
 
BFLY Butterfly Network, Inc.
2.2300
-1.76%